Oral triazolam is potentially hazardous to patients receiving systemic antimycotics ketoconazole or itraconazole (Q56339150)
Jump to navigation
Jump to search
article by Anu Varhe et al published December 1994 in Clinical Pharmacology & Therapeutics
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Oral triazolam is potentially hazardous to patients receiving systemic antimycotics ketoconazole or itraconazole |
article by Anu Varhe et al published December 1994 in Clinical Pharmacology & Therapeutics |
Statements
Oral triazolam is potentially hazardous to patients receiving systemic antimycotics ketoconazole or itraconazole (English)
0 references
December 1994
0 references
56
0 references
6
0 references
601-607
0 references